Appendix cancer, once considered rare, is increasingly affecting younger adults, particularly those born since the 1970s. Research indicates a three to fourfold increase in diagnoses compared to older ...
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of ...
Most people have never given their appendix much thought. Fewer still have heard of appendiceal cancer. But new research suggests this rare disease is becoming far less rare among younger ...
Brian Johnson was told his type of cancer was so rare, doctors in his home state of Oregon only see about three cases per year. As if an appendiceal cancer diagnosis for a middle-aged father wasn’t ...
From left, Dr. Vadim Guschin, Director of Mercy’s heated chemotherapy (HIPEC) program and a member of the Surgical Oncology Department, and Armando Sardi, M.D., Medical Director of The Institute for ...
The efficacy and safety of sosimerasib monotherapy in pretreated colorectal cancer with KRAS G12C mutation: Results from a phase 1b study. A multicenter randomized phase II trial assessing the ...
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma Approximately one in ...
Saturday will mark a 20-year legacy for Frank “Dutch” Culbertson as family and friends gather to add to the more than $2 million raised for appendix cancer research through a walk in his memory. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results